In addition, deletion of de novo DNA methyltransferase 3 alpha (DNMT3A) provided overall resistance to CAR-T cell exhaustion, which exhibited enhanced proliferation, in vivo persistence, and tumor control in prolonged tumor exposure (121). The gene discussed is DNMT3A; the disease is neoplasm.